Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 1, 2006

iOWH Awarded $46M to Fight Diarrhea

  • The Institute for OneWorld Health (iOWH) was awarded a $46 million from the Bill & Melinda Gates Foundation to expand its research on new treatments to complement traditional approaches for fighting diarrhea.

    OneWorld Health’s research aims to develop new treatments for secretory diarrheal disease, particularly antisecretory drugs that inhibit the loss of fluid in the intestine. These drugs are designed to be used as an adjunct to oral rehydration therapy for the treatment of E. coli and cholera, which are responsible for nearly 40% of reported cases of diarrheal disease.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »